Genomic spectrum of actionable alterations in serial cell free DNA (cfDNA) analysis of patients with metastatic breast cancer

Genomic spectrum of actionable alterations in serial cell free DNA (cfDNA) analysis of patients with metastatic breast cancer

Abstract We aimed to study the incidence and genomic spectrum of actionable alterations (AA) detected in serial cfDNA collections from patients with metastatic breast cancer (MBC). Patients with MBC who underwent plasma-based cfDNA testing (Guardant360®) between 2015 and 2021 at an academic institut...

Full description

Bibliographic Details
Main Authors: Yael Bar, Jennifer C. Keenan, Andrzej Niemierko, Arielle J. Medford, Steven J. Isakoff, Leif W. Ellisen, Aditya Bardia, Neelima Vidula
Format: Article
Language:English
Published: Nature Portfolio 2024-04-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-024-00633-7

Internet

https://doi.org/10.1038/s41523-024-00633-7

Similar Items